Dysregulation of the major signaling cascades, such as MAPK, PI3K/PTEN/AKT, JAK/STAT3, Notch, and NF-KB, promotes malignant tumor phenotypes (chemoresistant, metastatic, and proliferative), ultimately leading to poor clinical outcomes [25]. This evidence concerns the gene PTEN and neoplasm.